PATENT CLAIM ANALYSIS

Application Number: 15938837
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "399000"]

Abstract:
Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.

Claim (Index 80):
The formulation of  claim 1 , wherein the formulation further comprises one or more additional ingredients selected from the group consisting of:\n a. vitamins, minerals and carbohydrates; or b. choline, inositol, vitamin A, vitamin D, vitamin E, vitamin K, vitamin C, thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, biotin, pantothenic acid, potassium, calcium, magnesium, iron, zinc, copper, manganese, selenium, chromium, molybdenum, iodine, sodium, sulfur, phosphorus, docosahexaenoic acid, eicosapentaenoic acid, arachidonic acid, and lutein, and salts, chelates, esters and other derivatives thereof.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15655924', '12714181', '12433510', '10364793', '10943356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7402596257553156
- 35 USC 102 Novelty (BERT): 0.5209146301196
- Combined Prediction Score: 0.718325126191744
- Mean Citation Score: 224.945836
- Max Citation Score: 259.45892000000003
- Similarity Product: 151.8343578053141

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test